Merck takeover $1.75 a share, page-107

Merk get all the assets. Going back to the basic machinations today. Merk have made a move at the lowest price they thought could be swallowed. Good results coming out later, in conjunction with their lead product in this space, so make a move now - good commercial sense. BUT, from the BOD point of view they have simply started a process - very much like a house auction where the auctioneer says "the property will be sold, we have reached a level that the owner will accept". The wording of the documentation says in principle that Viralytics will be sold to Merk UNLESS A BETTER OFFER IS RECEIVED." Auction is now open.
I've owned VLA since 2009 and have watched this forum without a need to be involved.
Don't panic.